BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sample DA, Sunwoo HH, Huynh HQ, Rylance HL, Robert CL, Xu BW, Kang SH, Gujral N, Dieleman LA. AGY, a Novel Egg Yolk-Derived Anti-gliadin Antibody, Is Safe for Patients with Celiac Disease. Dig Dis Sci 2017;62:1277-85. [PMID: 28035551 DOI: 10.1007/s10620-016-4426-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Yoosuf S, Makharia GK. Evolving Therapy for Celiac Disease.Front Pediatr. 2019;7:193. [PMID: 31157194 DOI: 10.3389/fped.2019.00193] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
2 Klonarakis M, Andrews CN, Raman M, Panaccione R, Ma C. Review article: therapeutic targets for the pharmacologic management of coeliac disease-the future beyond a gluten-free diet. Aliment Pharmacol Ther 2022;55:1277-96. [PMID: 35229332 DOI: 10.1111/apt.16846] [Reference Citation Analysis]
3 Vacca M, Porrelli A, Calabrese FM, Lippolis T, Iacobellis I, Celano G, Pinto D, Russo F, Giannelli G, De Angelis M. How Metabolomics Provides Novel Insights on Celiac Disease and Gluten-Free Diet: A Narrative Review. Front Microbiol 2022;13:859467. [DOI: 10.3389/fmicb.2022.859467] [Reference Citation Analysis]
4 Van Buiten CB, Elias RJ. Gliadin Sequestration as a Novel Therapy for Celiac Disease: A Prospective Application for Polyphenols. Int J Mol Sci 2021;22:E595. [PMID: 33435615 DOI: 10.3390/ijms22020595] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Leiva CL, Gallardo MJ, Casanova N, Terzolo H, Chacana P. IgY-technology (egg yolk antibodies) in human medicine: A review of patents and clinical trials. Int Immunopharmacol 2020;81:106269. [PMID: 32036273 DOI: 10.1016/j.intimp.2020.106269] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
6 Kivelä L, Caminero A, Leffler DA, Pinto-Sanchez MI, Tye-Din JA, Lindfors K. Current and emerging therapies for coeliac disease. Nat Rev Gastroenterol Hepatol 2021;18:181-95. [PMID: 33219355 DOI: 10.1038/s41575-020-00378-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
7 Kulkarni A, Patel S, Khanna D, Parmar MS. Current pharmacological approaches and potential future therapies for Celiac disease. Eur J Pharmacol 2021;909:174434. [PMID: 34418405 DOI: 10.1016/j.ejphar.2021.174434] [Reference Citation Analysis]
8 Vaquero L, Bernardo D, León F, Rodríguez-martín L, Alvarez-cuenllas B, Vivas S. Challenges to drug discovery for celiac disease and approaches to overcome them. Expert Opinion on Drug Discovery 2019;14:957-68. [DOI: 10.1080/17460441.2019.1642321] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]